Metformin discount agreements: Agreement between AOKs and Dexcel Pharma GmbH

14.08.2012 12:05

The general local health insurance companies (AOKs) and Dexcel Pharma GmbH (DPG) have resolved the differences of opinion in connection with the termination of the metformin discount contracts by mutual agreement. DPG has agreed to terminate the metformin discount agreements for reasons unrelated to the allegations made by the AOKs. The agreement has no impact on the current discount agreements for the active ingredients amlodipine and losartan/HCT or on current or future award procedures and does not prejudice the AOKs' award decisions on discount contract tenders in which DPG participates.